0000899243-22-016638.txt : 20220504
0000899243-22-016638.hdr.sgml : 20220504
20220504170928
ACCESSION NUMBER: 0000899243-22-016638
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220502
FILED AS OF DATE: 20220504
DATE AS OF CHANGE: 20220504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bhatia Sangeeta N.
CENTRAL INDEX KEY: 0001643921
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 22892529
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-02
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001643921
Bhatia Sangeeta N.
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2022-05-02
4
S
0
40
255.40
D
6600
D
Common Stock
2022-05-02
4
S
0
280
257.51
D
6320
D
Common Stock
2022-05-02
4
S
0
120
258.90
D
6200
D
Common Stock
2022-05-02
4
S
0
120
259.75
D
6080
D
Common Stock
2022-05-02
4
S
0
80
260.82
D
6000
D
Common Stock
2022-05-02
4
S
0
91
261.91
D
5909
D
Common Stock
2022-05-02
4
S
0
6
264.37
D
5903
D
Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.
Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $257.51 (range $257.15 to $258.09).
Open market sales reported on this line occurred at a weighted average price of $258.90 (range $258.32 to $259.19).
Open market sales reported on this line occurred at a weighted average price of $259.75 (range $259.35 to $260.14).
Open market sales reported on this line occurred at a weighted average price of $260.82 (range $260.49 to $261.15).
Open market sales reported on this line occurred at a weighted average price of $261.91 (range $261.69 to $262.09).
/s/ Sabrina Yohai, Attorney-in-Fact
2022-05-04